4Oeeulmlinnal Safety end Health Administration US Department of Isbor.Technieal Links 》 Osha Technical ManuaI.Controlling occupational exposure to hazanlous drugs.1993.
5Ziegler E, Mason H J,Baxter P J. Occupational exposure to cytotoxic drugs in two UK oncology wards[J].Occupational and Environmental Medicine, 2002, 59(9) :608.
6Fuchs J, Hengstler J G, Jung D, et al. DNA damage in nurses handling anti-neuoplasctic agents [J]. Mutat Res,1995,342(1-2) :17.
7Sorsa M, Anderson D. Monitoring of occupational exposure to cytostatic anticancer agents[J]. Mutat Res,1996,335(1-2) :253.
8Jakab MG, Major J, Tompa A. Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs[J]. Toxical Environ Health A,2001,62(5) :307.
9Newman A, Valanis G, Schoeny S. Urinary biological monitoring markers of anticancer drug exposure in oncology nurses[J]. Am J Public Health, 1994,84 (5):852.